Skip to main content

Table 2 Baseline characteristics of patients with uppr gastrointestinal bleeding

From: AIMS65 scoring system is comparable to Glasgow-Blatchford score or Rockall score for prediction of clinical outcomes for non-variceal upper gastrointestinal bleeding

CharacteristicsN (%)
Overall512 (100)
Median age (range), years64 (48–80)
Male368 (71.9)
Comorbidities;
 None115 (30.3)
 Hypertension97 (18.9)
 Diabetes mellitus78 (15.2)
 Cerebrovascular disease56 (13.2)
 Liver disease47 (9.2)
 Chronic renal impairment40 (7.8)
 Ischemic heart disease30 (5.9)
 Malignancy26 (5.1)
 Congestive cardiac failure19 (3.7)
 Chronic obstructive airways disease17 (3.3)
Bleeding risk medications;
 None327 (63.9)
 Aspirin101 (19.7)
 Nonsteroidal anti-inflammatory drugs38 (7.4)
 Clopidogrel35 (6.8)
 Warfarin11 (2.1)
Bleeding cause of endoscopic finding;
 Gastric ulcer168 (32.8)
 Duodenal ulcer105 (20.5)
 Mallory Weiss tear67 (13.1)
 Acute gastric mucosal lesion66 (12.9)
 Dieulafoy’s lesion34 (6.6)
 Gastrointestinal malignancy34 (6.6)
 Angiodysplasia21 (4.1)
 Esophageal ulcer17 (3.3)
Serious clinical outcomes;
 Mortality17 (3.3)
 Rebleeding65 (12.7)
 ICU admission86 (16.8)
Treatment;
 None211 (41.2)
 Argon plasma coagulation216 (42.2)
 Hemostatic forcep coagulation30 (5.9)
 Hemoclipping55 (10.7)
 Epinephrine injection18 (3.5)
 Embolization7 (14)
 Band ligation1 (0.2)
Mean (95% CI) score;
 AIMS65 score1.1 (0.1–2.1)
 Pre-endoscopy Rockall score3.1 (1.4–4.8)
 Full Rockall score5.6 (4.3–7.8)
 Glasgow-Blatchford score9.6 (5.4–13.6)